Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$0.22 - $0.5 $11,000 - $25,000
50,000 Added 71.43%
120,000 $36,000
Q1 2023

May 15, 2023

BUY
$0.36 - $0.63 $3,600 - $6,300
10,000 Added 16.67%
70,000 $25,000
Q4 2022

Feb 14, 2023

SELL
$0.41 - $18.6 $4,100 - $186,000
-10,000 Reduced 14.29%
60,000 $28,000
Q3 2022

Nov 14, 2022

BUY
$0.57 - $34.65 $11,399 - $693,000
20,000 Added 40.0%
70,000 $60,000
Q1 2022

May 17, 2022

BUY
$1.16 - $2.5 $46,400 - $100,000
40,000 Added 400.0%
50,000 $66,000
Q3 2021

Nov 12, 2021

SELL
$5.1 - $9.39 $86,108 - $158,540
-16,884 Reduced 62.8%
10,000 $85,000
Q4 2020

Feb 08, 2021

BUY
$1.73 - $2.13 $46,509 - $57,262
26,884 New
26,884 $56,000

Others Institutions Holding PAVM

# of Institutions
1
Shares Held
2.24M
Call Options Held
0
Put Options Held
0

About PAVmed Inc.


  • Ticker PAVM
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 90,999,104
  • Market Cap $93.7M
  • Description
  • PAVmed Inc. operates as a medical device company in the United States. The company's lead products include CarpX, a percutaneous device to treat carpal tunnel syndrome; and EsoCheck, an esophageal cell collection device for the early detection of adenocarcinoma of the esophagus and Barrett's Esophagus (BE); and EsoGuard, a bisulfite-converted ne...
More about PAVM
Track This Portfolio

Track Lido Advisors, LLC Portfolio

Follow Lido Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lido Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lido Advisors, LLC with notifications on news.